Eric Swayze, EVP Research at IONIS PHARMACEUTICALS INC (IONS), sold 1,367 shares at $32.31 ($44K) on 2025-01-31, disclosed to the SEC on 2025-02-03.
Open-market sale of $44k IONS by EVP Research. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| IONS | SELL | 2026-02-02 | $512K | — | Filing → |
| IONS | SELL | 2026-01-20 | $748K | — | Filing → |
| IONS | SELL | 2026-01-06 | $1.9M | — | Filing → |